AbbVie drops Shire acquisition deal

Chicago-based pharmaceutical company AbbVie Inc. said it is dropping its $55 billion bid for Irish drug maker Shire, Reuters reported on October 20.

The U.S. drug maker is required to pay Shire a breakup fee of $1.64 billion after deciding to walk away from the acquisition deal. AbbVie’s board of directors decided to pull out from the deal after the U.S. Treasury Department initiated some amendments that would make it more difficult for companies to enjoy lower business tax rates by relocating to another country.

Business transactions designed to help your business thrive and grow can be affected by certain state and federal legislative changes. If you are considering entering into business transactions but are having difficulties navigating the legal complexities accompanying such deals, the experienced attorneys at Young, Cotter & Meade, LLC, might be of help. Contact our offices in Louisiana at (337) 376-2813 today to learn more about our services.

Leave a Reply

Your email address will not be published. Required fields are marked *